S-ICD Electrode Registry
Multicenter Registry for S-ICD Electrodes
1 other identifier
observational
1,000
1 country
1
Brief Summary
The subcutaneous implantable cardioverter defibrillator (S-ICD) is established in the prevention of sudden cardiac death, but recently a defect of the electrode's Sense-B component was reported in some patients. This lead to inadequate shocks due to noise. The cause and incidence of this defect are unknown. The manufacturer issued a warning regarding this defect and a possible premature depletion of the battery in some device. Independent data on the incidence of these issues is limited. Further data is needed to better understand the risk of these complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 6, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2024
CompletedOctober 13, 2023
October 1, 2023
1 year
January 27, 2023
October 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sense B Electrode Failure
Incidence of the Sense B Electrode Failure of the S-ICD Lead.
3 months to 70 months after device insertion
Secondary Outcomes (1)
Premature Battery Depletion
3 months to 70 months after device insertion
Eligibility Criteria
All patients who received an S-ICD at the participating sites for whom meaningful follow-up data is available will be included.
You may qualify if:
- \- status post S-ICD insertion
You may not qualify if:
- \- no available follow-up data beyond 2 weeks after insertion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Cologne
Cologne, North Rhine-Westphalia, 50937, Germany
Related Publications (4)
Luker J, Strik M, Andrade JG, Raymond-Paquin A, Elrefai MH, Roberts PR, Perez OC, Kron J, Koneru J, Franqui-Rivera H, Sultan A, Ernst A, Schmitt J, Pott A, Veltmann C, Srinivasan NT, Collinson J, van Stipdonk AMW, Linz D, Fluschnik N, Tonnis T, Haeberlin A, Ploux S, Steven D. Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry. J Interv Card Electrophysiol. 2025 Oct;68(7):1409-1415. doi: 10.1007/s10840-023-01468-1. Epub 2023 Jan 18.
PMID: 36652082BACKGROUNDHaeberlin A, Burri H, Schaer B, Koepfli P, Grebmer C, Breitenstein A, Reichlin T, Noti F. Sense-B-noise: an enigmatic cause for inappropriate shocks in subcutaneous implantable cardioverter defibrillators. Europace. 2023 Feb 16;25(2):767-774. doi: 10.1093/europace/euac202.
PMID: 36353759BACKGROUNDWormann J, Strik M, Jurisic S, Stout K, Elrefai M, Becher N, Schaer B, van Stipdonk A, Srinivasan NT, Ploux S, Breitenstein A, Kron J, Roberts PR, Toennis T, Linz D, Dulai R, Hermes-Laufer J, Koneru J, Erkuner O, Dittrich S, van den Bruck JH, Schipper JH, Sultan A, Rosenberger KD, Steven D, Luker J. Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patients. Europace. 2024 Jul 2;26(7):euae170. doi: 10.1093/europace/euae170.
PMID: 38885309DERIVEDWormann J, Strik M, Jurisic S, Stout K, Elrefai M, Becher N, Schaer B, van Stipdonk A, Srinivasan NT, Ploux S, Breitenstein A, Kron J, Roberts PR, Toennis T, Linz D, Dulai R, Hermes-Laufer J, Koneru J, Erkuner O, Dittrich S, van den Bruck JH, Schipper JH, Sultan A, Rosenberger KD, Steven D, Luker J. Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry. Europace. 2024 Jun 3;26(6):euae161. doi: 10.1093/europace/euae161.
PMID: 38861398DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2023
First Posted
February 6, 2023
Study Start
November 1, 2023
Primary Completion
November 1, 2024
Study Completion
November 3, 2024
Last Updated
October 13, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share